A new pattern-based method for identifying recent HIV-1 infections from the viral env sequence

Science China Life Sciences

Volumn 55, Issue 4, 2012, Pages 328-335

  Yang, Jing ^a   Xia, XiaYu ^a   He, Xiang ^b   Yang, SenLin ^b   Ruan, YuHua ^b   Zhao, QuanBi ^b   Wang, ZhiXin ^a   Shao, YiMing ^b   Pan, XianMing ^a  

^a TSINGHUA UNIVERSITY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

determination of HIV recent infections; estimation of population incidence; pattern based distance; viral genetic diversity

Indexed keywords

COMPLEMENTARY DNA; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

ALGORITHM; ARTICLE; BIOLOGICAL MODEL; BLOOD; CHEMISTRY; DNA SEQUENCE; GENETIC VARIABILITY; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METHODOLOGY; MOLECULAR GENETICS; MOLECULAR PATHOLOGY; NUCLEOTIDE SEQUENCE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TIME; VIROLOGY;

ALGORITHMS; DNA, COMPLEMENTARY; GENETIC VARIATION; HIV INFECTIONS; HIV-1; HUMANS; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; PATHOLOGY, MOLECULAR; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; TIME FACTORS; VIRAL ENVELOPE PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84860710266     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-012-4312-0     Document Type: Article

References (25)

1. Hall H I, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA, 2008, 300: 520-529.
2. Brookmeyer R. Measuring the HIV/AIDS epidemic: approaches and challenges. Epidemiol Rev, 2010, 32: 26-37.
3. Dobbs T, Kennedy S, Pau CP, et al. Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion. J Clin Microbiol, 2004, 42: 2623-2628.
4. Guy R, Gold J, Calleja J M, et al. Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence: a systematic review. Lancet Infect Dis, 2009, 9: 747-759.
5. Hargrove J W, Humphrey J H, Mutasa K, et al. Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay. AIDS, 2008, 22: 511-518.
6. Loschen S, Batzing-Feigenbaum J, Poggensee G, et al. Comparison of the human immunodeficiency virus (HIV) type 1-specific immunoglobulin G capture enzyme-linked immunosorbent assay and the avidity index method for identification of recent HIV infections. J Clin Microbiol, 2008, 46: 341-345.
7. Karita E, Price M, Hunter E, et al. Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa. AIDS, 2007, 21: 403-408.
8. Hayashida T, Gatanaga H, Tanuma J, et al. Effects of low HIV type 1 load and antiretroviral treatment on IgG-capture BED-enzyme immunoassay. AIDS Res Hum Retroviruses, 2008, 24: 495-498.
9. UNAIDS Reference Group. UNAIDS Reference Group on estimates, modelling and projections-statement on the use of the BED assay for the estimation of HIV-1 incidence for surveillance or epidemic monitoring. Wkly Epidemiol Rec, 2006, 81: 40.
10. Herbeck J T, Nickle D C, Learn G H, et al. Human immunodeficiency virus type 1 env evolves toward ancestral states upon transmission to a new host. J Virol, 2006, 80: 1637-1644.
11. Shankarappa R, Margolick J B, Gange S J, et al. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol, 1999, 73: 10489-10502.
12. Lee H Y, Giorgi E E, Keele B F, et al: Modeling sequence evolution in acute HIV-1 infection. J Theor Biol, 2009, 261: 341-360.
13. Korber B, Muldoon M, Theiler J, et al. Timing the ancestor of the HIV-1 pandemic strains. Science, 2000, 288: 1789-1796.
14. Worobey M, Gemmel M, Teuwen D E, et al. Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature, 2008, 455: 661-664.
15. Yusim K, Peeters M, Pybus O G, et al. Using human immunodeficiency virus type 1 sequences to infer historical features of the acquired immune deficiency syndrome epidemic and human immunodeficiency virus evolution. Philos Trans R Soc Lond B Biol Sci, 2001, 356: 855-866.
16. Keele B F, Giorgi E E, Salazar-Gonzalez J F, et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci USA, 2008, 105: 7552-7557.
17. Haubold B, Pfaffelhuber P, Domazet-Loso M, et al. Estimating mutation distances from unaligned genomes. J Comput Biol, 2009, 16: 1487-1500.
18. Zhang Y, Shan H, Trizzino J, et al. HIV incidence, retention rate, and baseline predictors of HIV incidence and retention in a prospective cohort study of injection drug users in Xinjiang, China. Int J Infect Dis, 2007, 11: 318-323.
19. Palmer S, Kearney M, Maldarelli F, et al. Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis. J Clin Microbiol, 2005, 43: 406-413.
20. Larkin M A, Blackshields G, Brown N P, et al. Clustal W and Clustal X version 2. 0. Bioinformatics, 2007, 23: 2947-2948.
21. Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution, 1985, 39: 783-791.
22. Justman J, El-Sadr W M. AIDS response at a crossroads. Science, 2010, 329: 120.
23. WHO, UNAIDS, UNICEF. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. 2009.
24. Hallett T B, Ghys P, Barnighausen T, et al. Errors in 'BED'-derived estimates of HIV incidence will vary by place, time and age. PLoS ONE, 2009, 4: e5720.
25. Park S Y, Love T M, Nelson J, et al. Designing a genome-based HIV incidence assay with high sensitivity and specificity. AIDS, 2011, 25: 1-7.